Antagonism between Bacteriostatic and Bactericidal Antibiotics Is Prevalent

• DOI: 10.1128/aac.02463-14
• Publication Date: 2014-05-28T07:08:08Z
• Authors: Paolo S. Ocampo; Viktória Lázár; Balázs Papp; Markus Arnoldini; Pia Abel zur Wiesch; Róbert Busa-Fekete; Gergely Fekete; Csaba Pál; Martin Ackermann; Sebastian Bonhoeffer
• Keywords: 0301 basic medicine; 0303 health sciences; Antibiotics, Antineoplastic; Microbial Sensitivity Tests; Microfluidic Analytical Techniques; Cytostatic Agents; Time-Lapse Imaging; Anti-Bacterial Agents; High-Throughput Screening Assays; 3. Good health; 03 medical and health sciences; Escherichia coli; Single-Cell Analysis; Drug Antagonism

ABSTRACTCombination therapy is rarely used to counter the evolution of resistance in bacterial infections. Expansion of the use of combination therapy requires knowledge of how drugs interact at inhibitory concentrations. More than 50 years ago, it was noted that, if bactericidal drugs are most potent with actively dividing cells, then the inhibition of growth induced by a bacteriostatic drug should result in an overall reduction of efficacy when the drug is used in combination with a bactericidal drug. Our goal here was to investigate this hypothesis systematically. We first constructed time-kill curves using five different antibiotics at clinically relevant concentrations, and we observed antagonism between bactericidal and bacteriostatic drugs. We extended our investigation by performing a screen of pairwise combinations of 21 different antibiotics at subinhibitory concentrations, and we found that strong antagonistic interactions were enriched significantly among combinations of bacteriostatic and bactericidal drugs. Finally, since our hypothesis relies on phenotypic effects produced by different drug classes, we recreated these experiments in a microfluidic device and performed time-lapse microscopy to directly observe and quantify the growth and division of individual cells with controlled antibiotic concentrations. While our single-cell observations supported the antagonism between bacteriostatic and bactericidal drugs, they revealed an unexpected variety of cellular responses to antagonistic drug combinations, suggesting that multiple mechanisms underlie the interactions.